SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Press Releases
InFlectis BioScience Announces Promising Results for IFB-088 in a Phase 2a Clinical Study in Bulbar-Onset ALS Patients
February 6, 2025
 · 
3 min read
Press Releases
Izotropic Reschedules Investor Conference Presentation to March 13th
February 6, 2025
 · 
2 min read
Press Releases
PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson’s Disease
February 6, 2025
 · 
6 min read
Press Releases
NervGen Completes Dosing of First Subject in Subacute Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
February 6, 2025
 · 
7 min read
Press Releases
Medexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States
February 6, 2025
 · 
24 min read
Press Releases
CytoImmune Subscribes for 1,634,466 Hemostemix Common Shares
February 5, 2025
 · 
6 min read
Press Releases
Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 4, 2025
 · 
4 min read
Press Releases
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board
February 4, 2025
 · 
4 min read
Press Releases
Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects
February 4, 2025
 · 
6 min read
Press Releases
Medexus and Ontario’s Provincial Health Services Successfully Complete Agreements for Public Reimbursement of Trecondyv (treosulfan for injection) in Ontario, Canada
February 4, 2025
 · 
8 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us